Type 1 conventional dendritic cell fate and function are controlled by DC-SCRIPT

See allHide authors and affiliations

Science Immunology  02 Apr 2021:
Vol. 6, Issue 58, eabf4432
DOI: 10.1126/sciimmunol.abf4432

Article Information

vol. 6 no. 58

Published By: 
  • Received October 27, 2020
  • Accepted March 3, 2021
  • .

Author Information

  1. Shengbo Zhang1,2,
  2. Hannah D. Coughlan1,2,
  3. Mitra Ashayeripanah3,
  4. Simona Seizova1,2,
  5. Andrew J. Kueh1,2,
  6. Daniel V. Brown1,2,
  7. Wang Cao1,2,
  8. Nicolas Jacquelot1,2,
  9. Angela D’Amico1,2,
  10. Andrew M. Lew1,2,
  11. Yifan Zhan1,2,4,
  12. Christopher J. Tonkin1,2,
  13. Jose A. Villadangos3,5,
  14. Gordon K. Smyth1,6,
  15. Michaël Chopin1,2,*, and
  16. Stephen L. Nutt1,2,*,
  1. 1Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia.
  2. 2Department of Medical Biology, University of Melbourne, Parkville, VIC 3010, Australia.
  3. 3Department of Microbiology and Immunology, University of Melbourne at Peter Doherty Institute of Infection and Immunity, Melbourne, VIC 3010, Australia.
  4. 4Drug Discovery, Shanghai Huaota Biopharmaceutical Co. Ltd., Shanghai, China.
  5. 5Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC, Australia.
  6. 6School of Mathematics and Statistics, University of Melbourne, Parkville, VIC 3010, Australia.
  1. Corresponding author. Email: chopin{at} (M.C.); nutt{at} (S.L.N.)
  • * These authors contributed equally to this work.


Article usage

Article usage: March 2021 to April 2021

Mar 2021030
Apr 20211299111101994

Stay Connected to Science Immunology